{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T05:37:50Z","timestamp":1773034670717,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["QLK3-CT99-50727"],"award-info":[{"award-number":["QLK3-CT99-50727"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["BIO4 CT97-5053"],"award-info":[{"award-number":["BIO4 CT97-5053"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/s0002-9440(10)63388-3","type":"journal-article","created":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T00:04:05Z","timestamp":1296173045000},"page":"1289-1300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":330,"title":["Massive CA1\/2 Neuronal Loss with Intraneuronal and N-Terminal Truncated A\u03b242 Accumulation in a Novel Alzheimer Transgenic Model"],"prefix":"10.1016","volume":"165","author":[{"given":"Caty","family":"Casas","sequence":"first","affiliation":[]},{"given":"Nicolas","family":"Sergeant","sequence":"additional","affiliation":[]},{"given":"Jean-Michel","family":"Itier","sequence":"additional","affiliation":[]},{"given":"V\u00e9ronique","family":"Blanchard","sequence":"additional","affiliation":[]},{"given":"Oliver","family":"Wirths","sequence":"additional","affiliation":[]},{"given":"Nicolien","family":"van der Kolk","sequence":"additional","affiliation":[]},{"given":"Val\u00e9rie","family":"Vingtdeux","sequence":"additional","affiliation":[]},{"given":"Evita","family":"van de Steeg","sequence":"additional","affiliation":[]},{"given":"Gwena\u00eblle","family":"Ret","sequence":"additional","affiliation":[]},{"given":"Thierry","family":"Canton","sequence":"additional","affiliation":[]},{"given":"Herv\u00e9","family":"Drobecq","sequence":"additional","affiliation":[]},{"given":"Allan","family":"Clark","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Bonici","sequence":"additional","affiliation":[]},{"given":"Andr\u00e9","family":"Delacourte","sequence":"additional","affiliation":[]},{"given":"Jes\u00fas","family":"Benavides","sequence":"additional","affiliation":[]},{"given":"Christoph","family":"Schmitz","sequence":"additional","affiliation":[]},{"given":"G\u00fcnter","family":"Tremp","sequence":"additional","affiliation":[]},{"given":"Thomas A.","family":"Bayer","sequence":"additional","affiliation":[]},{"given":"Patrick","family":"Benoit","sequence":"additional","affiliation":[]},{"given":"Laurent","family":"Pradier","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0002-9440(10)63388-3_bib1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(94)92338-8","article-title":"Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease","volume":"344","author":"West","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S0002-9440(10)63388-3_bib2","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","article-title":"Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease","volume":"16","author":"Gomez-Isla","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/S0002-9440(10)63388-3_bib3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.278.5337.412","article-title":"Life and death of neurons in the aging brain","volume":"278","author":"Morrison","year":"1997","journal-title":"Science"},{"key":"10.1016\/S0002-9440(10)63388-3_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0070-2153(03)54011-X","article-title":"The secretases of Alzheimer's disease","volume":"54","author":"Wolfe","year":"2003","journal-title":"Curr Top Dev Biol"},{"key":"10.1016\/S0002-9440(10)63388-3_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1534-5807(02)00189-2","article-title":"Aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation","volume":"3","author":"Francis","year":"2002","journal-title":"Dev Cell"},{"key":"10.1016\/S0002-9440(10)63388-3_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/35024009","article-title":"Nicastrin modulates presenilin-mediated notch\/glp-1 signal transduction and betaAPP processing","volume":"407","author":"Yu","year":"2000","journal-title":"Nature"},{"key":"10.1016\/S0002-9440(10)63388-3_bib7","doi-asserted-by":"crossref","first-page":"11039","DOI":"10.1073\/pnas.211352598","article-title":"Presenilin, Notch, and the genesis and treatment of Alzheimer's disease","volume":"98","author":"Selkoe","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0002-9440(10)63388-3_bib8","first-page":"419","article-title":"Transgenic mouse models of Alzheimer's disease: phenotype and application","volume":"14","author":"Higgins","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/S0002-9440(10)63388-3_bib9","doi-asserted-by":"crossref","first-page":"13990","DOI":"10.1073\/pnas.222433299","article-title":"Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease","volume":"99","author":"Urbanc","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0002-9440(10)63388-3_bib10","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0002-9440(10)63235-X","article-title":"Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease","volume":"164","author":"Schmitz","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/S0002-9440(10)63388-3_bib11","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0002-9440(10)63202-6","article-title":"Building a more perfect beast: APP transgenic mice with neuronal loss","volume":"164","author":"Dickson","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/S0002-9440(10)63388-3_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0014-4886(03)00252-8","article-title":"Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP\/PS1 transgenic mice","volume":"184","author":"Blanchard","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/S0002-9440(10)63388-3_bib13","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1046\/j.1471-4159.2003.01818.x","article-title":"Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach","volume":"85","author":"Sergeant","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/S0002-9440(10)63388-3_bib14","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1097\/00001756-199704140-00043","article-title":"Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype","volume":"8","author":"Kwok","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/S0002-9440(10)63388-3_bib15","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1097\/00001756-199607080-00009","article-title":"A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years","volume":"7","author":"Campion","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/S0002-9440(10)63388-3_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1042\/bj3440461","article-title":"Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion","volume":"344","author":"Borchardt","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/S0002-9440(10)63388-3_bib17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1046\/j.1471-4159.2002.00901.x","article-title":"Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheimer's disease","volume":"81","author":"Sergeant","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/S0002-9440(10)63388-3_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1750-3639.2002.tb00442.x","article-title":"Intraneuronal APP\/A beta trafficking and plaque formation in beta-amyloid precursor protein and presenilin-1 transgenic mice","volume":"12","author":"Wirths","year":"2002","journal-title":"Brain Pathol"},{"key":"10.1016\/S0002-9440(10)63388-3_bib19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/path.897","article-title":"Brain Abeta amyloidosis in APPsw mice induces accumulation of presenilin-1 and tau","volume":"194","author":"Tomidokoro","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/S0002-9440(10)63388-3_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0891-0618(00)00066-1","article-title":"Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach","volume":"20","author":"Schmitz","year":"2000","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/S0002-9440(10)63388-3_bib21","doi-asserted-by":"crossref","first-page":"8717","DOI":"10.1523\/JNEUROSCI.20-23-08717.2000","article-title":"Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability","volume":"20","author":"Siman","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/S0002-9440(10)63388-3_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0197-4580(01)00267-6","article-title":"Normal brain development in PS1 hypomorphic mice with markedly reduced gamma-secretase cleavage of betaAPP","volume":"23","author":"Rozmahel","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.1016\/S0002-9440(10)63388-3_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/pr.54.3.469","article-title":"Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease","volume":"54","author":"Suh","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/S0002-9440(10)63388-3_bib24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nm0798-827","article-title":"Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity","volume":"4","author":"Geula","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/S0002-9440(10)63388-3_bib25","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/27351","article-title":"Neuron loss in APP transgenic mice","volume":"395","author":"Calhoun","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0002-9440(10)63388-3_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9440(10)64700-1","article-title":"Intraneuronal Abeta42 accumulation in human brain","volume":"156","author":"Gouras","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/S0002-9440(10)63388-3_bib27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1172\/JCI119536","article-title":"Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization","volume":"100","author":"LaFerla","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/S0002-9440(10)63388-3_bib28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5858\/2001-125-0489-IAAPDO","article-title":"Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome","volume":"125","author":"Gyure","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/S0002-9440(10)63388-3_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/13506120208995241","article-title":"Intraneuronal Abeta42 accumulation in Down syndrome brain","volume":"9","author":"Mori","year":"2002","journal-title":"Amyloid"},{"key":"10.1016\/S0002-9440(10)63388-3_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0304-3940(01)01876-6","article-title":"Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice","volume":"306","author":"Wirths","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/S0002-9440(10)63388-3_bib31","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/8438","article-title":"Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation","volume":"5","author":"Chui","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/S0002-9440(10)63388-3_bib32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/S0002-9440(10)63388-3_bib33","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1083\/jcb.200110119","article-title":"Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons","volume":"156","author":"Zhang","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1016\/S0002-9440(10)63388-3_bib34","first-page":"118","article-title":"Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein","volume":"17","author":"Kim","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/S0002-9440(10)63388-3_bib35","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1046\/j.1460-9568.1999.00698.x","article-title":"Accumulation of murine amyloidbeta42 in a gene-dosage-dependent manner in PS1 \u2018knock-in\u2019 mice","volume":"11","author":"Nakano","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1016\/S0002-9440(10)63388-3_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1365-4624.1997.00012.x","article-title":"Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing","volume":"1","author":"Baumeister","year":"1997","journal-title":"Genes Funct"},{"key":"10.1016\/S0002-9440(10)63388-3_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0896-6273(04)00182-5","article-title":"Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration","volume":"42","author":"Saura","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/S0002-9440(10)63388-3_bib38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0896-6273(95)90301-1","article-title":"Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques","volume":"14","author":"Saido","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/S0002-9440(10)63388-3_bib39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/35014735","article-title":"Presenilin-1 mutations in Alzheimer's disease","volume":"405","author":"Russo","year":"2000","journal-title":"Nature"},{"key":"10.1016\/S0002-9440(10)63388-3_bib40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0304-3940(96)12970-0","article-title":"Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain","volume":"215","author":"Saido","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/S0002-9440(10)63388-3_bib41","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0014-5793(97)00564-4","article-title":"Heterogeneity of water-soluble amyloid beta-peptide in Alzheimer's disease and Down's syndrome brains","volume":"409","author":"Russo","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/S0002-9440(10)63388-3_bib42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00005072-199801000-00009","article-title":"N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits","volume":"57","author":"Tekirian","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/S0002-9440(10)63388-3_bib43","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1006\/bbrc.2000.3490","article-title":"Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain","volume":"276","author":"Harigaya","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S0002-9440(10)63388-3_bib44","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"10.1016\/S0002-9440(10)63388-3_bib45","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1021\/bi015800g","article-title":"Glu11 site cleavage and N-terminally truncated A beta production upon BACE overexpression","volume":"41","author":"Liu","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/S0002-9440(10)63388-3_bib46","doi-asserted-by":"crossref","first-page":"16278","DOI":"10.1074\/jbc.M111141200","article-title":"Beta-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain","volume":"277","author":"Huse","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/S0002-9440(10)63388-3_bib47","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0969-9961(03)00035-4","article-title":"Presenilin-1 interacts directly with the beta-site amyloid protein precursor cleaving enzyme (BACE1)","volume":"13","author":"Hebert","year":"2003","journal-title":"Neurobiol Dis"},{"key":"10.1016\/S0002-9440(10)63388-3_bib48","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0006-291X(02)00351-0","article-title":"BACE1 interacts with nicastrin","volume":"293","author":"Hattori","year":"2002","journal-title":"Biochem Biophys Res Commun"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010633883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010633883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:20:38Z","timestamp":1757600438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010633883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0002944010633883"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9440(10)63388-3","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Massive CA1\/2 Neuronal Loss with Intraneuronal and N-Terminal Truncated A\u03b242 Accumulation in a Novel Alzheimer Transgenic Model","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9440(10)63388-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}